For Yale’s Emerging Psychiatrists, Confronting Racism Is in the Curriculum
“The social justice curriculum is an important part of our broader effort to improve the culture of our department with respect to diversity and inclusion, and to bring the many legacies of racism to an end as rapidly as we can,” said department chair Dr. John Krystal.Source: YaleNews
Among young sober drivers, their history of alcohol use may be a key factor in how easily they are able to maintain attention while driving
Relationships between recent binge drinking, number of drinking-related symptoms, and the neural correlates of attention processing which may translate to limitations in secondary task engagement during driving simulation while sober.
Stress and Resilience Town Halls Are Being Offered
The Yale Department of Psychiatry continues to offer virtual “Stress and Resilience Town Halls” over Zoom that are open to all faculty, residents, and staff at Yale School of Medicine and Yale New Haven Health. Virtual meetings will run for up to an hour. Individuals can attend as frequently as they like.
Stress, Anxiety, or Depression? Treatment Starts With the Right Diagnosis
Wherever constant stress lives, so too does its more agitated and debilitating cousin: anxiety. About 31% of Americans will experience an anxiety disorder at some point in their lives. What’s more, anxiety often goes hand-in-hand with depression.Source: Yale Medicine
The promise of parent-child education programs on improving parenting practices and reducing stress in conflict-exposed families
Yale led research study shows that early childhood parenting education programs have a positive impact on disciplinary practices and parenting stress for families that experience humanitarian crises such as exposure to conflict, displacement, and economic marginalization.
Stress and Resilience Town Halls
Beginning Friday, March 20, the Department of Psychiatry will offer virtual “Stress and Resilience town halls” over Zoom that are open to all faculty, residents, students, and staff at Yale School of Medicine and Yale New Haven Health. Virtual meetings will take place twice daily and run for up to an hour. Individuals can attend as frequently as they like.
Yale School of Medicine and FDA’s Office of Minority Health and Health Equity Diversity Day: "Patient Centered Approach to Care and Research" on Feb. 28
The Innovation and Diversity Summit will focus on raising awareness about the need for minorities and subpopulation participation in clinical trials; patient-centered approaches to care and research; and the role of technology in both areas.
Are Benzodiazepines the New Opioids?
Yale addiction specialists believe the primary care system can play a key role in preventing another medication epidemic. David A. Fiellin, MD, worries that otherwise, the trajectory of benzodiazepine prescriptions might lead to a situation that resembles the opioid crisis.Source: Yale Medicine
Antidepressants Are Safe: Final Word?
Results from a large umbrella review of 45 meta-analyses that included > 1000 observational studies show that “there is no convincing evidence of a link between antidepressant use and adverse health outcomes.” According to Medscape: “Some experts urge caution in interpreting the results. "While the methods of this review are sound … and the discussion of these meta-analyses is balanced, an important limitation of meta-analysis and umbrella reviews is the risk of reductionism," write Michael Bloch, MD, Victor Avila-Quintero, MD, and Jose Flores, MD, PhD, all from Yale University School of Medicine. The editorialists say determining the risks of medication exposure during pregnancy is "important and of great concern" to families, physicians, and children. "Systematic reviews, meta-analyses, and the umbrella reviews will report more precise estimates of associations that are subject to confounding and bias, leading to false accuracy and certainty," they conclude.Source: Antidepressants Are Safe: Final Word?
Treatment Resistant Depression&Rapid-Acting Antidepressants
Ketamine, originally used as an anesthesia medicine and later abused as a "club drug," may be one of the most important developments for treating depression. Dr. John H. Krystal, M.D., chair of the Yale School of Medicine Department of Psychiatry and professor of translational research, psychiatry and neuroscience, discusses his groundbreaking study on the subject.Source: PBS
Krystal Among New Leaders of YCCI
The Yale Center for Clinical Investigation (YCCI) has announced the appointment of Brian R. Smith, MD, and John H. Krystal, MD ’84, as co-directors of the center and co-principal investigators of Yale’s Clinical and Translational Science Award (CTSA). Eric Jose Velazquez, MD, becomes deputy director of clinical trials innovation for YCCI.
Krystal and Nunez-Smith Are Honored by Association for Clinical and Translational Science
John H. Krystal, MD, Robert L. McNeil, Jr. Professor of Translational Research, chair and professor of psychiatry, and professor of neuroscience; and Marcella Nunez-Smith, MD, MHS, associate professor of medicine (general medicine) and of epidemiology (chronic diseases), have been chosen for awards by the Association for Clinical and Translational Science.
Yale Child Study Center to Partner with Scholastic on New Literacy Research
The Yale Child Study Center and Scholastic have launched a new joint research endeavor: the Yale Child Study Center–Scholastic Collaborative for Child & Family Resilience. The collaborative will focus on the intersection of literacy and health across a range of education content areas — i.e. early childhood, social emotional learning and teaching, equity and social justice, and family and community engagement — with the ultimate goal of improving academic and mental health outcomes for children and their families.